7aMoDi

Music title: تلك الدار الأخرة | الشيخ مشاري العفاسي والشيخ سعيد الكملي | برنامج آية وحكاية 3 Signer: Alafasy Release date: 2024/03/11 Official YouTube link:

Video title: you laugh 6,9 times, you restart Content creator ( Youtuber ) : momem Official YT video:

VOTED✔️

#Accepted! Message me here or in discord T/C.

Yes! @Scarlet Goulding?

VOTED✔️

VOTED✔️

VOTED✔️

#Accepted! T/C.

Yes! @WHAT IS GOING ON?

#Accepted! T/C.

VOTED✔️

The Long Range Dual Motor version has 483 hp and a claimed range of 315 miles, and the Performance upgrade brings power to 510 hp but drops range to 279 miles. The 2025 Polestar 3 starts at $74,800 and ranges up to $86,300. There will be two configurations, the 483-hp Long Range Dual Motor and the 510-hp Long Range Dual Motor Performance. Polestar says U.S. deliveries will start in the second quarter of 2024. As Polestar prepares to launch its third model, the 2025 Polestar 3, it's releasing additional pricing information and specs about this new electric SUV model that's slated to arrive in the U.S. this summer. It now carries a lower starting price of $74,800 thanks to a newly announced base model, and range estimates are between 279 miles on the low end and 315 miles on the upper end. That base price is for the Polestar 3 Long Range Dual Motor version, which has 483 horsepower and 620 pound-feet of torque. It comes standard with the Pilot Pack, which includes numerous driver-assistance features, and offers the Plus pack as an option for $5500. The Plus Pack includes an upgraded audio system, heated rear seats, 21-inch wheels, and other equipment. These versions are all estimated to deliver 315 miles of range from a 107.0-kWh battery pack, though we're still waiting to hear final EPA ratings. The more powerful Performance configuration has a starting price of $80,800 and ups the ante to 510 horsepower and 671 pound-feet of torque. It also offers the Plus Pack as a $5500 option. The range estimate for this version drops down to 279 miles. Polestar says it has already started production in China, and that U.S. deliveries will begin in the second quarter of this year. Later in the year, it plans to start production of the Polestar 3 at the Volvo plant in Charleston, South Carolina. Despite being raised on a steady diet of base-model Hondas and Toyotas—or perhaps because of it—Joey Capparella nonetheless cultivated an obsession for the automotive industry throughout his childhood in Nashville, Tennessee. He found a way to write about cars for the school newspaper during his college years at Rice University, which eventually led him to move to Ann Arbor, Michigan, for his first professional auto-writing gig at Automobile Magazine. He has been part of the Car and Driver team since 2016 and now lives in New York City. https://www.caranddriver.com/news/a60179302/2025-polestar-3-price-specs/

Martin Ødegaard celebrates after scoring his penalty in the shootout against Porto. Photograph: Zac Goodwin/PA Martin Ødegaard believes Arsenal’s dramatic shootout win over Porto can be the springboard for a sustained tilt at Champions League and Premier League honours over the final stages of the season. Arsenal squeaked through at the Emirates after a deliciously tense, attritional two legs that finished 1-1 on aggregate. They are in the last eight of Europe’s elite competition for the first time in 14 years and, given they lead England’s top flight after eight straight wins, a return to their days of landing major trophies looks tantalisingly close. The influential Ødegaard shrugged off the disappointment of seeing a potential winner ruled out in normal time to emphatically convert Arsenal’s first penalty. Asked whether such a watershed victory would be a coming of age for a side who remain inexperienced on this stage, he urged them to seize the opportunity it presents and harness their momentum. “I think we have to use this, we have to grow off this,” he said. “It is a massive night for everyone. We are still a young squad, but this was another big experience for everyone. We have to keep building on that and use it in a good way going into the end of the season. “I think it is a massive boost for everyone. The way we did it also, it maybe wasn’t the best game but you just saw everyone pushing so hard, digging so deep, and I think you saw the mentality in the team when we stepped up for the penalties. I am really proud of everyone.” Porto presented a tough and niggly test, although they arguably matched Arsenal’s attacking threat on Tuesday night. The challenge is likely to become yet more formidable in a quarter-final draw, to be held on Friday, that includes Real Madrid, Barcelona, Manchester City, Paris Saint-Germain and Bayern Munich. Ødegaard maintains, though, that Arsenal must not worry about any hierarchy of potential opponents. “We can’t think like that,” he said. “It’s the biggest tournament in the world and no matter what team we get, it’s going to be a good team. We will just take what we get and we will try to win. We want to be on the biggest stage. We want to play the biggest games and fight for the biggest trophies.” https://www.theguardian.com/football/2024/mar/13/martin-degaard-tells-arsenal-to-build-on-big-experience-of-victory-over-porto

Large chains could be squeezing out independent practices, says Competition and Markets Authority Nils Pratley: competition watchdog is barking up a promising tree Independent practices accounted for 45% of UK operators in 2021, down from 89% in 2013. Photograph: Ievgen Chabanov/Alamy The UK competition regulator is preparing to launch a formal investigation into the veterinary market after identifying “multiple concerns” in an initial review, including that pet owners may be overpaying for treatments and medicines. The Competition and Markets Authority (CMA) said it wanted to move forward with a full review after an initial inquiry triggered an “unprecedented response” from 56,000 people, including customers and vet professionals, who raised a number of concerns about practices within the £2bn industry. The watchdog is concerned that consumers may not be given enough information to make informed decisions over care, and that a rise in consolidation resulting in fewer independent surgeries has weakened competition. Since 2013, about 1,500 of the 5,000 vet practices in the UK have been acquired by six of the largest corporate groups: CVS, IVC, Linnaeus, Medivet, Pets at Home and VetPartners, the CMA said. Sarah Cardell, the CMA chief executive, said: “Our review has identified multiple concerns with the market that we think should be investigated further. These include pet owners finding it difficult to access basic information like price lists and prescription costs – and potentially overpaying for medicines. “We are also concerned about weak competition in some areas, driven in part by sector consolidation, and the incentives for large corporate groups to act in ways which may reduce competition and choice. “Given these strong indications of potential concern, it is time to put our work on a formal footing. We have provisionally decided to launch a market investigation because that’s the quickest route to enable us to take direct action, if needed.” Independent vet practices accounted for 45% of UK veterinary practices in 2021, down from 89% in 2013. The number of pet owners has also increased, primarily as a result of the pandemic, with about 17m households having a furry companion in the UK. The regulator is concerned that the larger corporations dominating the sector may be incentivised to act in a way that reduces choice for customers, leaving pet owners overpaying for medicines or prescriptions. Owing to their scale and ability to invest in advanced equipment, larger companies may concentrate on offering more sophisticated, and therefore higher-cost, treatment that crowds out more affordable options. Meanwhile, about 25% of pet owners were not aware they had an option to get prescriptions filled more cheaply elsewhere, meaning they were missing out on potential savings, even when accounting for prescription fees. Medicine sales make up about a quarter of the income of some vet practices, leaving little incentive to ensure clients were informed of other options. The CMA said the situation suggested the regulatory framework may be outdated and no longer be fit for purpose. Most of the industry’s regulations date to 1966, and primarily cover individual veterinary surgeons rather than non-vet owners, like the corporations that own the majority of sites today. It means the Royal College of Veterinary Surgeons has limited leverage, including over transparency of pricing and and the true ownership structure of chain-owned practices. The provisional view is that outcomes for consumers could be improved if regulatory requirements and/or elements of best practice could be monitored or enforced more effectively,” the CMA said. It will run a four-week consultation, before launching a formal investigation, giving it power to potentially mandate that vets give certain information to consumers, cap prescription fees or order the sale of businesses or assets, which could include breaking up some vet chains. The industry body, the British Veterinary Association (BVA), welcomed prospects for reform, saying that regulation was “not fit for purpose” and was failing vet teams and clients. However, while price rises were a concern for everyone, the BVA said it was “vital to recognise there is no NHS for pets.” “Whether they are employed by corporate or independently owned practices, vets deliver highly specialised, tailored care for the UK’s pets and the cost is a fair reflection of investment in medical equipment, supplies and medicines, and the time vet teams dedicate to the care of each patient,” the BVA president, Anna Judson, said. “At the British Veterinary Association, we’re keen to see healthy competition and consumer choice and so we are already taking steps to support vet practices to be more transparent both in terms of costs and practice ownership. It’s important that clients have as wide a choice of vet practices as possible so they can find a service that best suits the needs of themselves and their animals,” Judson added. “We will continue to engage constructively with the CMA by responding to this latest consultation and will continue to play a leadership role in driving positive change for vets and their clients.” https://www.theguardian.com/business/2024/mar/12/uk-vet-pricing-competition-and-markets-authority-cma